| Literature DB >> 35614409 |
Farzaneh Afkhami1, Shahrzad Razavi2, Sholeh Ghabraei3.
Abstract
BACKGROUND: This study aimed to assess the effect of different commercially used calcium hydroxide [Ca(OH)2], the mixture of Ca(OH)2 + silver nanoparticles (AgNPs), and other intracanal medicaments on dislodgement resistance of mineral trioxide aggregate (MTA) to root canal dentin in short- and long-term application.Entities:
Keywords: Bond strength; Calcium hydroxide; Intracanal medicaments; Mineral trioxide aggregate; Nanoparticles; Root canal disinfection
Mesh:
Substances:
Year: 2022 PMID: 35614409 PMCID: PMC9131544 DOI: 10.1186/s12903-022-02213-2
Source DB: PubMed Journal: BMC Oral Health ISSN: 1472-6831 Impact factor: 3.747
Preparation of mixtures and experimental groups
| Groups | Medicaments | Composition/manufacturer |
|---|---|---|
| Ca(OH)2 | Calcium hydroxide paste | Calcium hydroxide powder (i-dental, Šiauliai, Lithuania) mixed with normal saline with a ratio of 3:1 |
| Calcipex | Calcium hydroxide paste | Calcipex II, Nishika, Japan |
| Metapex | Calcium hydroxide with iodoform | Metabiomed, Chungbuk, Korea |
| CHX | 2% Chlorhexidine | Ultradent, Koln, Germany |
| Ca(OH)2/CHX | Calcium hydroxide and chlorhexidine paste | 1:1 ratio; (Calcipex II, Nishika, Japan)/(Ultradent, Koln, Germany) |
| Ca(OH)2/AgNPs | Calcium hydroxide powder and silver nanoparticles suspension | Calcium hydroxide powder (i-dental, Šiauliai, Lithuania)/silver nanoparticles suspension (50 ppm, size ~ 20 nm) with a ratio of 3:1 |
| TAP | Triple antibiotic paste | Metronidazole (Parsdarou, Tehran, Iran), Ciprofloxacin (Aria, Tehran, Iran), Minocycline (HEXAL AG, Holzkirchen, Germany) with a ratio of 1:1:1 |
| NS | Control group | Normal Saline: 0.9% NaCl |
Fig. 1Inspection of the species under a stereomicroscope (× 40) A: Adhesive failure, B: cohesive failure, C: mixed failure
The mean and standard deviation (SD) of the samples
| Groups | Mean ± SD (MPa) | ||
|---|---|---|---|
| 1 week (n = 10) | 1 month (n = 10) | P value | |
| Ca(OH)2 | 2.58 ± 1.56 | 2.13 ± 0.93 | 0.434 |
| Calcipex | 2.93 ± 1.97 | 1.75 ± 1.11 | 0.455 |
| Metapex | 2.45 ± 1.52 | 2.07 ± 1.72 | 0.575 |
| CHX | 3.08 ± 1.78 | 3.24 ± 1.92 | 0.006 |
| Ca(OH)2/CHX | 2.42 ± 0.99 | 2.82 ± 1.60 | 0.169 |
| Ca(OH)2/AgNPs | 2.56 ± 1.16 | 2.20 ± 1.99 | 0.402 |
| TAP | 2.03 ± 1.59 | 1.40 ± 0.77 | 0.996 |
| NS | 1.64 ± 0.70 | 1.11 ± 0.67 | |
No significant difference was noted between the experimental groups (P > 0.05). The only significant difference in dislodgement resistance was between the control (NS) and CHX groups (P = 0.006). The P values between the experimental groups and control group were shown in the table
The frequency of different modes of failure for each group
| Groups | Time | n | Adhesive | Cohesive | Mixed |
|---|---|---|---|---|---|
| Ca(OH)2 | 1 week | 10 | 4 | 2 | 4 |
| 1 month | 10 | 2 | 4 | 4 | |
| Calcipex | 1 week | 10 | 5 | 1 | 3 |
| 1 month | 10 | 5 | 0 | 5 | |
| Metapex | 1 week | 10 | 5 | 1 | 4 |
| 1 month | 10 | 4 | 1 | 5 | |
| CHX | 1 week | 10 | 6 | 1 | 3 |
| 1 month | 10 | 3 | 0 | 7 | |
| Ca(OH)2/CHX | 1 week | 10 | 2 | 1 | 7 |
| 1 month | 10 | 4 | 1 | 5 | |
| Ca(OH)2/AgNPs | 1 week | 10 | 4 | 2 | 4 |
| 1 month | 10 | 3 | 1 | 6 | |
| TAP | 1 week | 10 | 6 | 4 | 0 |
| 1 month | 10 | 7 | 2 | 1 | |
| NS | 1 week | 10 | 6 | 0 | 4 |
| 1 month | 10 | 3 | 1 | 6 | |
| Total (%) | 43.12% | 13.75% | 43.12% |